Filing Flows

Filing Flows › Xilio Therapeutics (XLO) › Who owns the stock

Who owns Xilio Therapeutics (XLO) stock

26 funds reported Xilio Therapeutics (XLO) shares in their latest 13F filings, worth $26.4M in all. The largest holder is Bain Capital Life Sciences Investors, LLC ($6.4M). Last quarter 15 funds added to their stakes and 11 cut them.

Largest holders of XLO (13F)Largest holders of XLO (13F)Bain Capital Life Sciences Invest…$6.4MOrbimed Advisors LLC$5.7MFrazier Life Sciences Management,…$4.0MStonepine Capital Management, LLC$2.2MVanguard Capital Management LLC$1.7MSio Capital Management, LLC$1.5MAdage Capital Partners GP, L.L.C.$1.1MMerck$1.0MRenaissance Technologies LLC$615KMorgan Stanley$546K

Largest holders (13F)

FundSharesValueChangeQuarter
Bain Capital Life Sciences Investors, LLC664,021$6.4Munchanged2026-06-30
Orbimed Advisors LLC592,300$5.7Mnew2026-06-30
Frazier Life Sciences Management, L.P.422,505$4.0Munchanged2026-06-30
Stonepine Capital Management, LLC225,994$2.2Mnew2026-06-30
Vanguard Capital Management LLC178,517$1.7Mincrease2026-06-30
Sio Capital Management, LLC152,464$1.5Munchanged2026-06-30
Adage Capital Partners GP, L.L.C.111,541$1.1Mnew2026-06-30
Merck105,982$1.0Munchanged2026-06-30
Renaissance Technologies LLC64,153$615Kincrease2026-06-30
Morgan Stanley56,954$546Kdecrease2026-06-30
Geode Capital Management, LLC39,055$374Kincrease2026-06-30
Citadel Advisors LLC25,950$249Knew2026-06-30
Vanguard Fiduciary Trust22,594$216Kdecrease2026-06-30
Bridgeway Capital Management, LLC17,544$168Knew2026-06-30
Two Sigma Investments, LP14,544$139Knew2026-06-30

Xilio Therapeutics' latest quarter

Xilio Therapeutics, Q2 2026: revenue $18.7M (+131% year over year), operating margin -18.7%, net loss $6.4M, operating cash flow −$18.8M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most XLO stock?

By the latest 13F filings: Bain Capital Life Sciences Investors, LLC ($6.4M); Orbimed Advisors LLC ($5.7M); Frazier Life Sciences Management, L.P. ($4.0M); Stonepine Capital Management, LLC ($2.2M); Vanguard Capital Management LLC ($1.7M).

What is the short interest in XLO?

400,316 shares were sold short at the 2026-10-15 settlement, -2.37% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.